This is a preview of subscription content, log in via an institution to check access.
References
Hwang TJ, et al. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs. JAMA Internal Medicine : 14 Jan 2019. Available from: URL: http://doi.org/10.1001/jamainternmed.2018.6417
Venker B, et al. Assessment of Spending in Medicare Part D If Medication Prices From the Department of Veterans Affairs Were Used. JAMA Internal Medicine : 14 Jan 2019. Available from: URL: http://doi.org/10.1001/jamainternmed.2018.5874
Crosson FJ, et al. Managing the Cost of Medicare Part B Drugs: Implications for the Program and Beneficiaries. JAMA Internal Medicine : 14 Jan 2019. Available from: URL: http://doi.org/10.1001/jamainternmed.2018.6146
Rights and permissions
About this article
Cite this article
Shift to Medicare Part D may reduce total drug expenditure. PharmacoEcon Outcomes News 821, 29 (2019). https://doi.org/10.1007/s40274-019-5646-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5646-7